Harbin pharmaceutical stockholders approved funding capacity of Heilongjiang e can encounter the question

After three years of Harbin pharmaceutical group (600664) ownership battle finally draw a "full stop". Harbin pharmaceutical group yesterday's announcement that its controlling shareholder Harbin pharmaceutical group co., Ltd sticks has the consent of the State. Harbin pharmaceutical group will be State-owned company "make up" as the State holding co., Ltd.　　While previous Heilongjiang chenergy-hit hi-tech venture capital co., Ltd. General Manager Zhao qingbin jump from, as well as the company's $ 300 million of stolen funds, did not affect its equity ratio of Harbin pharmaceutical group. After enlargement, Harbin pharmaceutical group's ownership structure for Harbin municipal SASAC holds its 45% of the State-owned property; CITIC capital investment co., Ltd. holds its Iceland 22.5% of property rights; huaping Iceland investment co., Ltd. holds its 22.5% of property rights; Heilongjiang chenergy-hit hi-tech venture capital co., Ltd. holds 10% of the State-owned property. Harbin pharmaceutical group has on 1 July, the nature of the shares was completed Reregistration process.

According to Harbin pharmaceutical group prior to this announcement, CITIC, huaping, Heilongjiang e can be by cash RMB 20.35 billion to Harbin pharmaceutical group co., Ltd. reorganized. And the reorganization of Hayao expected objectives is that in 2005 the value of $ 13 billion, profits reached 18 million to become China's pharmaceutical carriers.

Previously, Hayao reorganization was once encountered the "variables". The beginning of the year, one of a sudden burst of recombinant e of Heilongjiang, stored in Bank of China branch in Harbin, Heilongjiang River Pine Street branch of the deposit is $ 3.2 branch subordinate branch officer Division, Alpine mountains have been missing. Subsequently, the General Manager Zhao Qing Chen-to-pin on January 13, was killed in a suicide units. As of the end of 2003, e of the energy of total assets and net assets of $ 7.06 6.52 billion, and in order to restructure Harbin pharmaceutical group, could be financed 3.7 e. Thus, the industry can ability of capital e.